GBA Presents: THE GREEN MARKET

settlement $'s?

  • Sonos(NASDAQ:SONO)is 0.5% highertoday after giving up some earlier gains following a victory at the International TradeCommission in a fight over patents with Google(GOOG-0.7%,GOOGL-0.7%) - and Morgan Stanley says the win brings Sonos a bit closer to monetizing its intellectual property.
  • The ruling is "further proof that Sonos has industry-leading IP that they can successfully defend in court," analyst Katy Huberty and team write.
  • It might not bring any direct monetary benefit - the ITC only implements trade-related rulings - but it proves two important points, Morgan Stanley says. First, "Sonos indeed has industry-leading audio technology IP," and second, "they can successfully defend said IP against competitors they believe unfairly infringe upon their technology."
  • Sonos has defended IP and negotiated licensing deals with smaller competitors, but Google is of a different scale, the firm says.
  • The audio company now has more negotiating power to either work out a licensing deal out of court, or use the ruling to strengthen its court case against Google (currently stayed) in California's Central District - where it could gain monetary rewards in the form of damages or an ongoing license payment.
  • One caution is that Google appears willing to keep making its case, meaning a negotiated settlement is the best case scenario vs. a protracted patent-infringement battle that could last years.
  • Morgan Stanley has an Overweight rating on Sonos with a $49 price target, now implying 69% upside.
 
Roblox slides after taking down China app to build new version 11:14 RBLX, TCEHY Shares of Roblox (RBLX) are down about 7%, to $6.20, to $83.00 after Reuters reported that the LuoBuLesi app, which the company launched in July in partnership with an affiliate of Tencent Holdings (TCEHY), was shut down on December 8 and now shows users a message thanking them for using the test version when they log on. A Roblox spokesperson told Reuters late on Thursday that the move was necessary as the company builds the "next version of LuoBuLeSi," but did not say when the app would return, according to the news service's report. "We always knew that building a compelling platform in China is an iterative process, and we are thankful for the support of LuoBuLeSi users and our global developer community. It is critical that we now make the necessary investments, including investments in our data architecture, in order to realize our long-term vision," a Roblox spokesperson is quoted as having said
 
>Tips + News>Air Travel
Why European Airlines Are Flying Empty Planes




Jan 6, 2022


original_shutterstock_1398361952.jpg



“The high-level pollution created by these flights runs totally counter to the EU’s climate objectives.”

With an Omicron-fueled drop in demand, planes continue to fly in Europe even without passengers so that airlines won’t lose their airport slots. But what about climate concerns?
 
stonedinvestor said:
With an Omicron-fueled drop in demand, planes continue to fly in Europe even without passengers so that airlines won’t lose their airport slots.
More...
Who are they gonna lose the slots to if they're all flying empty lol?

Re FDX----- old news. Every company in the world is seeing people call in sick. Omicron's a flash in the pan. Already priced in.

Now Sonos....
stonedinvestor said:
settlement $'s?

  • Sonos(NASDAQ:SONO)is 0.5% highertoday after giving up some earlier gains following a victory at the International TradeCommission
More...


  • Stoney, even if they get a settlement, that's what's called a one time gain. It's just like a one time loss. Analysts don't really care all that much. Unless its paid out as a special dividend, which I strongly suspect Sonos won't do lol. It's a business, an ongoing operation. You don't base future growth on today's legal windfalls. Now if that ruling applies to their model going forward, then it's something to consider. That, and hopefully they'll reinvest the windfall into the company. So it might be a slight positive... depending on how astute their management is with the dollars in, dollars out, aspect of growing profits per dollar spent.
    Is this the speaker company btw?
    Lol... I wouldn't touch it. For growth or a trade.
    CRSR is better down here.

    stonedinvestor said:
    Van-

    JPMorgan says own these medical device stocks into next week's conference 07:41

    BSX, INSP, ABT, EW, PEN, ATRC, DXCM Into his firm's healthcare conference next week, JPMorgan analyst Robbie Marcus recommends owning medical device stocks that either likely won't be preannouncing "but can still talk to a bullish long-term outlook," or stocks that could preannounce a Q4 beat off "appropriately conservative expectations." For the former, Marcus recommends Boston Scientific (BSX), Inspire Medical (INSP), Abbott (ABT), Edwards Lifesciences (EW) and Penumbra (PEN). For the latter, Marcus recommends AtriCure (ATRC) and DexCom (DXCM), though he notes that DexCom "will probably guide very conservatively" to 15%-20% growth in 2021.
    More...

    He left out long time VZ favorite... SYK. Styker. They make artificial bones or whatever it is people get when they have hip or knee replacements. I recommended this in the last thread at $250ish.

    Re RBLX. I thought you liked RBLX? Didn't you say you were going long?

    stonedinvestor said:
    Ok folks so when you wantto know which is the most powerful tech stock you look to days like teses to tel you.



    Roblox Corporation (RBLX) I think you are good to go Van

    88.54-6.61(-6.95%)
    At close: 04:00PM EST
    More...

    stonedinvestor said:
    I'd go with RBLX and then I came back on and told you the price which you got.

    I'm buying tomorrow.
    More...
 
Love me some RBLX! Yup waiting for just the right price. It had a seperate China issue I posted about.. you need to keep up with the RBLX. It is the most searched symbol now I do not know why.

Biotech due to bounce back, Vertex stands out, Barron's says 10:00 VRTX Biotech stocks began the year in much the same way they ended it-by getting hammered. Vertex Pharmaceuticals, however, held its own, and that may be reason enough to start nibbling at its shares, Ben Levisohn writes in this week's edition of Barron's. Looking ahead, large-cap biotech will offer a smoother ride than small, and Vertex, in particular, looks attractive, the author contends. <---------:thumbsup:
 
Simply The Best!

Investors should buy MGM, winning streak doesn't have to end, Barron's says 09:57 MGM Given the big gain in MGM Resorts' stock last year, investors might be tempted to take their winnings off the table, Lawrence Strauss writes in this week's edition of Barron's. But the casino operator still has some good cards to play in 2022, the author adds.<-----------:thumbsup:
 
Way to go Abbot labs donating 300,00 test kits to Chicago now get those kids back in school!

Dear Apple-

I found a way to sooth my wife's flaming anger at me not doing anything. This lack of fun around the house... well it's that great Apple corporation - i-pad.Pro. She is so happy now. Life is fun again. She has that camera she needs for the pictures she needs to take for her jewelry bizz. I've probably bought myself 5 years.
 
stonedinvestor said:
Way to go Abbot labs donating 300,00 test kits to Chicago now get those kids back in school!

Dear Apple-

I found a way to sooth my wife's flaming anger at me not doing anything. This lack of fun around the house... well it's that great Apple corporation - i-pad.Pro. She is so happy now. Life is fun again. She has that camera she needs for the pictures she needs to take for her jewelry bizz. I've probably bought myself 5 years.
More...
New buzz-word Stoney...
"Deltacron".

Scientists Identify Coronavirus Strain In Cyprus—‘Deltacron’—That Blends Delta And Omicron
Lisa Kim
Forbes Staff
Business
Topline
Scientists in Cyprus have found 25 cases of a strain of the coronavirus that they say combines elements of the delta and omicron variants, dubbing it “deltacron,” with a high proportion of the variant found in patients hospitalized for Covid-19, a professor involved in the identification of the new strain said Saturday.
 
You must log in or register to reply here.
Back
Top